$CMXC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cell MedX Corp..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cell MedX Corp.. Get notifications about new insider transactions in Cell MedX Corp. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.28 | 22,150 | 6,202 | 5,653,252 | 5.7 M to 5.7 M (-0.39 %) |
| Apr 30 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.28 | 22,150 | 6,202 | 5,653,252 | 5.7 M to 5.7 M (-0.39 %) |
| Apr 30 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.28 | 10,000 | 2,800 | 5,675,402 | 5.7 M to 5.7 M (-0.18 %) |
| Apr 30 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.28 | 10,000 | 2,800 | 5,675,402 | 5.7 M to 5.7 M (-0.18 %) |
| Apr 30 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.27 | 10,000 | 2,700 | 5,685,402 | 5.7 M to 5.7 M (-0.18 %) |
| Apr 30 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.27 | 10,000 | 2,700 | 5,685,402 | 5.7 M to 5.7 M (-0.18 %) |
| Apr 26 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.26 | 10,000 | 2,600 | 5,695,402 | 5.7 M to 5.7 M (-0.18 %) |
| Apr 26 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.26 | 25,000 | 6,500 | 5,705,402 | 5.7 M to 5.7 M (-0.44 %) |
| Apr 21 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.27 | 24,780 | 6,567 | 5,730,402 | 5.8 M to 5.7 M (-0.43 %) |
| Apr 21 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.25 | 22,562 | 5,641 | 5,755,182 | 5.8 M to 5.8 M (-0.39 %) |
| Apr 21 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.25 | 27,438 | 6,860 | 5,777,744 | 5.8 M to 5.8 M (-0.47 %) |
| Apr 21 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.25 | 22,562 | 5,641 | 5,805,182 | 5.8 M to 5.8 M (-0.39 %) |
| Apr 19 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.22 | 23,500 | 5,217 | 5,827,744 | 5.9 M to 5.8 M (-0.40 %) |
| Apr 07 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.23 | 20,000 | 4,628 | 5,851,244 | 5.9 M to 5.9 M (-0.34 %) |
| Mar 31 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technology & Ope ... | Sell | S | 0.22 | 25,000 | 5,450 | 5,909,855 | 5.9 M to 5.9 M (-0.42 %) |
| Mar 31 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technolgy & Oper ... | Sell | S | 0.27 | 18,911 | 5,106 | 5,871,244 | 5.9 M to 5.9 M (-0.32 %) |
| Mar 31 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP Technolgy & Oper ... | Sell | S | 0.30 | 19,700 | 5,910 | 5,890,155 | 5.9 M to 5.9 M (-0.33 %) |
| Feb 16 2021 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Gift | G | 0.00 | 300,000 | 0 | 5,934,855 | 6.2 M to 5.9 M (-4.81 %) |
| Sep 01 2020 | CMXC | Cell MedX Corp. | ARNETT JEAN M | 10% Owner | Option Exercise | M | 0.05 | 1,250,000 | 62,500 | 0 | |
| Sep 01 2020 | CMXC | Cell MedX Corp. | ARNETT JEAN M | 10% Owner | Buy | M | 0.05 | 1,250,000 | 62,500 | 6,250,000 | 5 M to 6.3 M (+25.00 %) |
| Sep 01 2020 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | M | 0.05 | 1,234,855 | 61,743 | 15,145 | |
| Sep 01 2020 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Buy | M | 0.05 | 1,234,855 | 61,743 | 6,234,855 | 5 M to 6.2 M (+24.70 %) |
| Sep 01 2020 | CMXC | Cell MedX Corp. | MCENULTY FRANK | President and CEO | Option Exercise | P | 0.35 | 40,000 | 14,000 | 40,000 | |
| Sep 01 2020 | CMXC | Cell MedX Corp. | MCENULTY FRANK | President and CEO | Buy | P | 0.25 | 40,000 | 10,000 | 521,016 | 481 K to 521 K (+8.32 %) |
| Apr 28 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Sell | S | 0.60 | 1,665 | 999 | 11,252,028 | 11.3 M to 11.3 M (-0.01 %) |
| Apr 28 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Sell | S | 0.60 | 15,607 | 9,364 | 11,253,693 | 11.3 M to 11.3 M (-0.14 %) |
| Apr 28 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.42 | 5,500 | 2,332 | 11,269,300 | 11.3 M to 11.3 M (+0.05 %) |
| Apr 28 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.15 | 1,000,000 | 150,000 | 11,263,800 | 10.3 M to 11.3 M (+9.74 %) |
| Apr 17 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.32 | 5,000 | 1,600 | 10,263,800 | 10.3 M to 10.3 M (+0.05 %) |
| Apr 17 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.33 | 5,000 | 1,648 | 10,258,800 | 10.3 M to 10.3 M (+0.05 %) |
| Apr 17 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.33 | 5,000 | 1,650 | 10,253,800 | 10.2 M to 10.3 M (+0.05 %) |
| Apr 16 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.31 | 10,000 | 3,100 | 10,248,800 | 10.2 M to 10.2 M (+0.10 %) |
| Apr 16 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.29 | 10,000 | 2,900 | 10,238,800 | 10.2 M to 10.2 M (+0.10 %) |
| Apr 16 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.31 | 10,000 | 3,100 | 10,248,800 | 10.2 M to 10.2 M (+0.10 %) |
| Apr 16 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 17,100 | 5,130 | 10,228,800 | 10.2 M to 10.2 M (+0.17 %) |
| Apr 16 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.29 | 10,000 | 2,900 | 10,238,800 | 10.2 M to 10.2 M (+0.10 %) |
| Apr 16 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 17,100 | 5,130 | 10,228,800 | 10.2 M to 10.2 M (+0.17 %) |
| Apr 13 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 5,300 | 1,590 | 10,211,700 | 10.2 M to 10.2 M (+0.05 %) |
| Apr 13 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 25,000 | 7,458 | 10,206,400 | 10.2 M to 10.2 M (+0.25 %) |
| Apr 13 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.29 | 8,000 | 2,320 | 10,181,400 | 10.2 M to 10.2 M (+0.08 %) |
| Apr 07 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.21 | 30,000 | 6,300 | 10,173,400 | 10.1 M to 10.2 M (+0.30 %) |
| Feb 10 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 10,000 | 2,970 | 10,143,400 | 10.1 M to 10.1 M (+0.10 %) |
| Jan 31 2020 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 10,133,400 | 10.1 M to 10.1 M (+0.10 %) |
| Dec 13 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.24 | 25,000 | 5,985 | 10,123,400 | 10.1 M to 10.1 M (+0.25 %) |
| Dec 13 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.24 | 25,000 | 5,985 | 10,123,400 | 10.1 M to 10.1 M (+0.25 %) |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | X | 0.05 | 3,000,000 | 150,000 | 2,000,000 | |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | X | 0.05 | 3,000,000 | 150,000 | 2,000,000 | |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | X | 0.05 | 2,000,000 | 100,000 | 5,000,000 | |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | X | 0.05 | 2,000,000 | 100,000 | 5,000,000 | |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | X | 0.05 | 2,482,960 | 124,148 | 7,000,000 | |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | X | 0.05 | 2,482,960 | 124,148 | 7,000,000 | |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | M | 0.05 | 7,482,960 | 374,148 | 10,098,400 | 2.6 M to 10.1 M (+286.11 %) |
| Sep 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | M | 0.05 | 7,482,960 | 374,148 | 10,098,400 | 2.6 M to 10.1 M (+286.11 %) |
| Aug 15 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.32 | 2,500 | 800 | 2,615,440 | 2.6 M to 2.6 M (+0.10 %) |
| Aug 15 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.31 | 6,064 | 1,850 | 2,612,940 | 2.6 M to 2.6 M (+0.23 %) |
| Aug 09 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.15 | 16,000 | 2,400 | 2,606,876 | 2.6 M to 2.6 M (+0.62 %) |
| Aug 02 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.15 | 14,700 | 2,132 | 2,590,876 | 2.6 M to 2.6 M (+0.57 %) |
| Jul 26 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.16 | 200 | 32 | 2,576,176 | 2.6 M to 2.6 M (+0.01 %) |
| Jul 19 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.18 | 8,500 | 1,530 | 2,575,976 | 2.6 M to 2.6 M (+0.33 %) |
| Jun 28 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.17 | 1,100 | 187 | 2,567,476 | 2.6 M to 2.6 M (+0.04 %) |
| Feb 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.14 | 50,000 | 7,000 | 2,566,376 | 2.5 M to 2.6 M (+1.99 %) |
| Feb 11 2019 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.12 | 250 | 30 | 2,516,376 | 2.5 M to 2.5 M (+0.01 %) |
| Dec 31 2018 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | A | 0.05 | 2,482,960 | 124,148 | 2,482,960 | |
| Dec 31 2018 | CMXC | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 5,000,000 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | J | 0.05 | 2,500,000 | 125,000 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | J | 0.05 | 2,500,000 | 125,000 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | J | 0.05 | 1,250,000 | 62,500 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | J | 0.05 | 1,250,000 | 62,500 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | J | 0.05 | 1,250,000 | 62,500 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | ARNETT JEAN M | 10% Owner | Option Exercise | J | 0.05 | 2,500,000 | 125,000 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | ARNETT JEAN M | 10% Owner | Option Exercise | J | 0.05 | 2,500,000 | 125,000 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | ARNETT JEAN M | 10% Owner | Option Exercise | J | 0.05 | 1,250,000 | 62,500 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | ARNETT JEAN M | 10% Owner | Option Exercise | J | 0.05 | 1,250,000 | 62,500 | 0 | |
| Aug 24 2018 | CMXC | Cell MedX Corp. | ARNETT JEAN M | 10% Owner | Option Exercise | J | 0.05 | 1,250,000 | 62,500 | 0 | |
| Oct 18 2017 | CMXC | Cell MedX Corp. | MCENULTY FRANK | President, CEO | Buy | P | 0.25 | 481,016 | 120,254 | 481,016 | 0 to 481 K |
| Oct 18 2017 | CMXC | Cell MedX Corp. | SILINA YANIKA S | CFO | Option Exercise | A | 0.35 | 300,000 | 105,000 | 300,000 | |
| Aug 23 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.29 | 1,000 | 290 | 2,516,126 | 2.5 M to 2.5 M (+0.04 %) |
| Aug 15 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 170 | 43 | 2,515,126 | 2.5 M to 2.5 M (+0.01 %) |
| Jun 19 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.27 | 2,690 | 726 | 2,514,956 | 2.5 M to 2.5 M (+0.11 %) |
| Jun 13 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.18 | 50,000 | 9,000 | 2,512,266 | 2.5 M to 2.5 M (+2.03 %) |
| May 15 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.35 | 5,000 | 1,750 | 2,462,266 | 2.5 M to 2.5 M (+0.20 %) |
| May 05 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.36 | 2,200 | 796 | 2,458,466 | 2.5 M to 2.5 M (+0.09 %) |
| May 05 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.43 | 600 | 258 | 2,456,266 | 2.5 M to 2.5 M (+0.02 %) |
| May 05 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.44 | 10,000 | 4,400 | 2,455,666 | 2.4 M to 2.5 M (+0.41 %) |
| Apr 12 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.32 | 5,190 | 1,661 | 2,445,666 | 2.4 M to 2.4 M (+0.21 %) |
| Mar 24 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.36 | 11,560 | 4,104 | 2,440,476 | 2.4 M to 2.4 M (+0.48 %) |
| Mar 24 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.36 | 10,000 | 3,600 | 2,428,916 | 2.4 M to 2.4 M (+0.41 %) |
| Mar 13 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 4,500 | 1,350 | 2,418,916 | 2.4 M to 2.4 M (+0.19 %) |
| Mar 13 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 2,414,416 | 2.4 M to 2.4 M (+0.21 %) |
| Mar 08 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 5,000 | 1,498 | 2,409,416 | 2.4 M to 2.4 M (+0.21 %) |
| Mar 08 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 5,000 | 1,513 | 2,404,416 | 2.4 M to 2.4 M (+0.21 %) |
| Mar 08 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.31 | 5,000 | 1,575 | 2,399,416 | 2.4 M to 2.4 M (+0.21 %) |
| Mar 08 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.29 | 5,000 | 1,450 | 2,394,416 | 2.4 M to 2.4 M (+0.21 %) |
| Mar 03 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.28 | 10,000 | 2,800 | 2,389,416 | 2.4 M to 2.4 M (+0.42 %) |
| Jan 23 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.31 | 10,000 | 3,100 | 2,360,432 | 2.4 M to 2.4 M (+0.43 %) |
| Jan 12 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 10,000 | 3,000 | 2,350,432 | 2.3 M to 2.4 M (+0.43 %) |
| Jan 09 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.30 | 10,000 | 3,000 | 2,340,432 | 2.3 M to 2.3 M (+0.43 %) |
| Jan 09 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.29 | 7,000 | 2,030 | 2,330,432 | 2.3 M to 2.3 M (+0.30 %) |
| Jan 09 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.28 | 26,500 | 7,420 | 2,323,432 | 2.3 M to 2.3 M (+1.15 %) |
| Jan 09 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.28 | 7,500 | 2,100 | 2,296,932 | 2.3 M to 2.3 M (+0.33 %) |
| Jan 09 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.28 | 5,000 | 1,400 | 2,289,432 | 2.3 M to 2.3 M (+0.22 %) |
| Jan 09 2017 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 2,500 | 625 | 2,284,432 | 2.3 M to 2.3 M (+0.11 %) |
| Dec 30 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.27 | 1,500 | 405 | 2,281,932 | 2.3 M to 2.3 M (+0.07 %) |
| Dec 30 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.26 | 3,000 | 780 | 2,280,432 | 2.3 M to 2.3 M (+0.13 %) |
| Dec 23 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.26 | 2,500 | 650 | 2,277,432 | 2.3 M to 2.3 M (+0.11 %) |
| Dec 23 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.26 | 2,500 | 650 | 2,274,932 | 2.3 M to 2.3 M (+0.11 %) |
| Dec 23 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.24 | 2,500 | 600 | 2,272,432 | 2.3 M to 2.3 M (+0.11 %) |
| Dec 16 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.22 | 100 | 22 | 2,269,932 | 2.3 M to 2.3 M (0.00 %) |
| Dec 08 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 2,269,832 | 2.3 M to 2.3 M (+0.22 %) |
| Dec 05 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.22 | 1,900 | 418 | 2,264,832 | 2.3 M to 2.3 M (+0.08 %) |
| Dec 05 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.24 | 9,200 | 2,208 | 2,262,932 | 2.3 M to 2.3 M (+0.41 %) |
| Dec 05 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.22 | 10,000 | 2,200 | 2,253,732 | 2.2 M to 2.3 M (+0.45 %) |
| Nov 25 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 2,243,732 | 2.2 M to 2.2 M (+0.45 %) |
| Nov 25 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.22 | 3,500 | 770 | 2,233,732 | 2.2 M to 2.2 M (+0.16 %) |
| Nov 15 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 1,500 | 375 | 2,230,232 | 2.2 M to 2.2 M (+0.07 %) |
| Nov 15 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 2,228,732 | 2.2 M to 2.2 M (+0.22 %) |
| Nov 15 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 1,000 | 250 | 2,223,732 | 2.2 M to 2.2 M (+0.04 %) |
| Nov 10 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 2,500 | 625 | 2,222,732 | 2.2 M to 2.2 M (+0.11 %) |
| Nov 10 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 2,220,232 | 2.2 M to 2.2 M (+0.45 %) |
| Nov 10 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.28 | 5,000 | 1,387 | 2,210,232 | 2.2 M to 2.2 M (+0.23 %) |
| Nov 03 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 2,205,232 | 2.2 M to 2.2 M (+0.23 %) |
| Oct 18 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.27 | 8,000 | 2,160 | 2,200,232 | 2.2 M to 2.2 M (+0.36 %) |
| Oct 06 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.22 | 10,000 | 2,200 | 2,192,232 | 2.2 M to 2.2 M (+0.46 %) |
| Sep 23 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.20 | 4,970 | 994 | 2,182,232 | 2.2 M to 2.2 M (+0.23 %) |
| Sep 23 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.20 | 30 | 6 | 2,177,262 | 2.2 M to 2.2 M (0.00 %) |
| Sep 14 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.20 | 5,000 | 1,000 | 2,177,232 | 2.2 M to 2.2 M (+0.23 %) |
| Sep 14 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.20 | 5,000 | 1,000 | 2,172,232 | 2.2 M to 2.2 M (+0.23 %) |
| Sep 14 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.20 | 14,332 | 2,866 | 2,167,232 | 2.2 M to 2.2 M (+0.67 %) |
| Aug 30 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.15 | 10,000 | 1,500 | 2,152,900 | 2.1 M to 2.2 M (+0.47 %) |
| Aug 19 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.17 | 10,250 | 1,743 | 2,142,900 | 2.1 M to 2.1 M (+0.48 %) |
| Aug 17 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.17 | 2,000 | 340 | 2,132,650 | 2.1 M to 2.1 M (+0.09 %) |
| Aug 17 2016 | PLDX | Cell MedX Corp. | JEFFS RICHARD | 10% Owner | Buy | P | 0.17 | 7,750 | 1,318 | 2,130,650 | 2.1 M to 2.1 M (+0.37 %) |
| Aug 06 2015 | PLDX | Cell MedX Corp. | MCENULTY FRANK | PRESIDENT AND CEO | Option Exercise | A | 0.30 | 500,000 | 150,000 | 500,000 | |
| Aug 06 2015 | PLDX | Cell MedX Corp. | MCENULTY FRANK | PRESIDENT AND CEO | Option Exercise | A | 0.30 | 500,000 | 150,000 | 500,000 | |
| Aug 06 2015 | PLDX | Cell MedX Corp. | MCENULTY FRANK | PRESIDENT AND CEO | Option Exercise | A | 0.30 | 500,000 | 150,000 | 500,000 | |
| Aug 06 2015 | PLDX | Cell MedX Corp. | MCENULTY FRANK | PRESIDENT AND CEO | Option Exercise | A | 0.30 | 500,000 | 150,000 | 500,000 | |
| Aug 06 2015 | PLDX | Cell MedX Corp. | MCENULTY FRANK | PRESIDENT AND CEO | Option Exercise | A | 0.30 | 500,000 | 150,000 | 500,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | A | 0.05 | 2,500,000 | 125,000 | 2,500,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | A | 0.05 | 2,500,000 | 125,000 | 2,500,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | HARGREAVES BRADLEY S | VP, Technology and ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | ARNETT JEAN M | VP, Corporate Strat ... | Option Exercise | A | 0.05 | 2,500,000 | 125,000 | 2,500,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | ARNETT JEAN M | VP, Corporate Strat ... | Option Exercise | A | 0.05 | 2,500,000 | 125,000 | 2,500,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | ARNETT JEAN M | VP, Corporate Strat ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | ARNETT JEAN M | VP, Corporate Strat ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | ARNETT JEAN M | VP, Corporate Strat ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 | |
| Dec 01 2014 | PLDX | Cell MedX Corp. | ARNETT JEAN M | VP, Corporate Strat ... | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 1,250,000 |
Page: 1